Rowan
Rowan

Rowan

DR18Ahrefs DR: 18/100. Bottom 25%. Measured by Ahrefs. Median 44.Agent50Agent Readiness: 50/100. Top 25%. Measured by StartupHub.ai. Median 41.

AI-powered molecular simulation for accelerating drug discovery and materials science.

ActiveSan Francisco, United States

About

Rowan leverages artificial intelligence to accelerate molecular simulation, significantly speeding up the process of discovering new drugs and designing novel materials. Their platform uses AI to predict molecular behavior and properties, offering a faster and more efficient approach to R&D in the life sciences and materials industries.

Key facts

At-a-glance profile data

Website
rowan.ai
Headquarters
San Francisco, United States
Total funding
-
Business model
B2B
Add first review